Gilead Sciences | 보통주 자본



Ordinary Share Capital 변화 날짜
AbbVie USD 18M 0 2024-12
Agios Pharmaceuticals USD 73K 0 2024-12
ALKERMES USD 1.77M 4K 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
Amgen USD 33.53B 140M 2024-12
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 193K 1000 2024-12
J&J USD 3.12B 0 2024-12
Merck USD 1.79B 0 2024-12
Moderna USD 38.6K 100 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 480M 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Sarepta Therapeutics USD 10K 0 2024-12
United Therapeutics USD 800K 100K 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Gilead Sciences 보통주 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2025.